Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Burning Rock Biotech Ltd BNR

Healthcare Biotechnology
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation... see more

Recent & Breaking News (NDAQ:BNR)

Burning Rock's Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology

GlobeNewswire April 13, 2021

Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 10, 2021

Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021

GlobeNewswire February 8, 2021

Oncocyte and Burning Rock Execute Strategic Agreement to Distribute DetermaRx in China

GlobeNewswire December 15, 2020

Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China

GlobeNewswire December 15, 2020

Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares

GlobeNewswire December 4, 2020

Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares

GlobeNewswire December 1, 2020

Burning Rock Reports Third Quarter 2020 Financial Results

GlobeNewswire November 20, 2020

Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China

GlobeNewswire November 15, 2020

Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting

GlobeNewswire October 29, 2020

Burning Rock to Present Data on Its Early Detection ELSA-seq at ESMO Asia Virtual Congress 2020

GlobeNewswire October 20, 2020

Burning Rock Announces Preliminary Third Quarter 2020 Results and Schedules Earnings Release on November 20, 2020

GlobeNewswire October 20, 2020

Burning Rock to Participate in Morgan Stanley 2020 Healthcare Conference

GlobeNewswire September 3, 2020

Burning Rock Reports Second Quarter 2020 Financial Results

GlobeNewswire August 11, 2020

Brenntag reports solid results for the second quarter of 2020

PR Newswire August 6, 2020

Burning Rock Schedules Second Quarter of 2020 Earnings Release on August 11, 2020

GlobeNewswire July 20, 2020

Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in China

GlobeNewswire June 28, 2020

Burning Rock Announces Full Exercise of Over-Allotment Option in Initial Public Offering

GlobeNewswire June 22, 2020

Brenntag Reports Solid Results for the First Quarter of 2020, with Increased Operating Gross Profit and Higher Operating EBITDA

PR Newswire May 7, 2020